Maged P. Ghali, M.D.

Maged P. Ghali M.D.

Professor & Chief, Division of Gastroenterology; Program Director, Gastroenterology Fellowship

Department: Department of Medicine
Business Phone: (904) 427-7275
Business Email: Maged.Ghali@jax.ufl.edu
Appointments and Locations

Board Certifications

  • Internal Medicine
  • Gastroenterology
  • Transplant Hepatology

Clinical Profile

Specialties
  • Gastroenterology
Languages
  • Speaks English and French

Publications

2021
Esophageal Perforation after Using a Single-Use Disposable Duodenoscope.
Case reports in gastroenterology.15(3):972-977[DOI] 10.1159/000519685.[PMID] 35110984.
2 citations·PubMed·Publisher's Site
2020
Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.
BMJ case reports.13(6):-[DOI] 10.1136/bcr-2020-234637.[PMID] 32601138.
PubMed·Publisher's Site
2019
What Patients Want in a Smartphone App That Supports Colonoscopy Preparation: Qualitative Study to Inform a User-Centered Smartphone App
JMIR mHealth and uHealth.7(7):e12242-[DOI] 10.2196/12242.[PMID] 31125310.
7 citations·PubMed·Publisher's Site
2017
Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients
Canadian Journal of Gastroenterology and Hepatology.2017():1-8[DOI] 10.1155/2017/4381864.[PMID] 28409147.
1 citations·PubMed·Publisher's Site

Office Information

Academic Office
3rd Floor, LRC
653-1 West 8th Street, L-13
Jacksonville, FL 32209
(904) 427-7275
 Maged.Ghali@jax.ufl.edu
Administrative Manager
 Joann Feliciano
(904) 427-7275
Joann.feliciano@jax.ufl.edu
GME Office
5th Floor, Tower 1, Suite 513
580 West 8th Street
Jacksonville, FL 32209
Phone: (904) 244-3092
 Maged.Ghali@jax.ufl.edu
Senior GME Program Administrator
 Jessica McDonald-Jazrawi, MBA, C-TAGME
(904) 244-3092
jessica.mcdonald-jazrawi2@jax.ufl.edu

Clinical Research

OPEN ENROLLMENT
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
TARGET-HCC: A 5 - year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
OPEN ENROLLMENT
A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease
OPEN ENROLLMENT
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate to Severe Crohn's Disease
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis

Education

Medical Degree
1998 · McGill University, Montreal, Canada
Internal Medicine Residency
2001 · McGill University Health Center -Royal Victoria Hospital, Montreal, Canada
Gastroenterology Fellowship
2004 · McGill University Health Center -Royal Victoria Hospital, Montreal, Canada
Transplant Hepatology Fellowship
2005 · Mayo Clinic, Rochester, MN, USA

Media Coverage

March 29, 2022
Study: Cancer numbers declining due to people not getting screened, warns patients can have worse outcomes
First Coast News